ATHE
Price
$2.20
Change
+$0.10 (+4.76%)
Updated
Dec 20, 04:59 PM (EDT)
SLDB
Price
$4.15
Change
+$0.14 (+3.49%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

ATHE vs SLDB

Header iconATHE vs SLDB Comparison
Open Charts ATHE vs SLDBBanner chart's image
Alterity Therapeutics
Price$2.20
Change+$0.10 (+4.76%)
Volume$100
CapitalizationN/A
Solid Biosciences
Price$4.15
Change+$0.14 (+3.49%)
Volume$16.91K
CapitalizationN/A
ATHE vs SLDB Comparison Chart
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. SLDB commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and SLDB is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ATHE: $2.20 vs. SLDB: $4.16)
Brand notoriety: ATHE and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 45% vs. SLDB: 291%
Market capitalization -- ATHE: $18.29M vs. SLDB: $166.21M
ATHE [@Biotechnology] is valued at $18.29M. SLDB’s [@Biotechnology] market capitalization is $166.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • ATHE’s TA Score: 4 bullish, 5 bearish.
  • SLDB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than ATHE.

Price Growth

ATHE (@Biotechnology) experienced а -8.33% price change this week, while SLDB (@Biotechnology) price change was -15.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ATHE is expected to report earnings on May 31, 2023.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($166M) has a higher market cap than ATHE($18.3M). ATHE YTD gains are higher at: -11.647 vs. SLDB (-32.248). ATHE has higher annual earnings (EBITDA): -14.25M vs. SLDB (-108.63M). ATHE (0) and SLDB (0) have equivalent revenues.
ATHESLDBATHE / SLDB
Capitalization18.3M166M11%
EBITDA-14.25M-108.63M13%
Gain YTD-11.647-32.24836%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A171M-
Total DebtN/A24.7M-
FUNDAMENTALS RATINGS
ATHE vs SLDB: Fundamental Ratings
ATHE
SLDB
OUTLOOK RATING
1..100
9750
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3589
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLDB's Valuation (22) in the Biotechnology industry is significantly better than the same rating for ATHE (88). This means that SLDB’s stock grew significantly faster than ATHE’s over the last 12 months.

SLDB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATHE (100). This means that SLDB’s stock grew similarly to ATHE’s over the last 12 months.

ATHE's SMR Rating (97) in the Biotechnology industry is in the same range as SLDB (98). This means that ATHE’s stock grew similarly to SLDB’s over the last 12 months.

ATHE's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for SLDB (89). This means that ATHE’s stock grew somewhat faster than SLDB’s over the last 12 months.

SLDB's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for ATHE (100). This means that SLDB’s stock grew significantly faster than ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHESLDB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEIZX13.320.23
+1.76%
Manning & Napier Callodine Equity Inc Z
IDPSX54.830.94
+1.74%
ProFunds Industrial Ultra Sector Svc
NSNCX48.540.33
+0.68%
Neuberger Berman Small Cap Growth C
LVOTX20.300.09
+0.45%
Lord Abbett Value Opportunities R5
APHIX27.04-0.02
-0.07%
Artisan International Institutional

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
+4.76%
EYPT - ATHE
54%
Loosely correlated
-0.28%
SLDB - ATHE
38%
Loosely correlated
+3.74%
KALA - ATHE
36%
Loosely correlated
-1.33%
BCLI - ATHE
33%
Loosely correlated
+9.62%
CVM - ATHE
29%
Poorly correlated
-4.60%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+3.74%
ACLX - SLDB
41%
Loosely correlated
+0.44%
TRDA - SLDB
41%
Loosely correlated
+1.79%
ABOS - SLDB
41%
Loosely correlated
+2.78%
MGTX - SLDB
38%
Loosely correlated
+5.31%
ATHE - SLDB
38%
Loosely correlated
+4.76%
More